570.33美元3.95(0.7%)
2024/05/03更新
績效 / 1月2.66%
3月0.73%
1年7.79%
晨星評等 - 1.現金0.00%
- 2.股票29.14%
- 3.債券0.00%
- 4.其他70.86%
- 1.美國70.86%
- 2.歐洲不包含歐元區18.35%
- 3.英國4.69%
- 4.歐元區2.33%
- 5.日本2.12%
- 1.健康護理99.15%
- 2.基本物料0.56%
- 3.防守性消費0.29%
- 1.Eli Lilly and Co8.21%
- 2.Novo Nordisk A/S Class B7.97%
- 3.UnitedHealth Group Inc7.46%
- 4.Merck & Co Inc6.04%
- 5.Roche Holding AG4.92%
- 6.GSK PLC4.69%
- 7.Regeneron Pharmaceuticals Inc4.62%
- 8.Elevance Health Inc4.28%
- 9.Vertex Pharmaceuticals Inc4.27%
- 10.Amgen Inc4.18%
- 1.現金0.00%
- 2.股票29.14%
- 3.債券0.00%
- 4.其他70.86%
- 1.健康護理99.15%
- 2.基本物料0.56%
- 3.防守性消費0.29%
- 1.美國70.86%
- 2.歐洲不包含歐元區18.35%
- 3.英國4.69%
- 4.歐元區2.33%
- 5.日本2.12%
- 1.Eli Lilly and Co8.21%
- 2.Novo Nordisk A/S Class B7.97%
- 3.UnitedHealth Group Inc7.46%
- 4.Merck & Co Inc6.04%
- 5.Roche Holding AG4.92%
- 6.GSK PLC4.69%
- 7.Regeneron Pharmaceuticals Inc4.62%
- 8.Elevance Health Inc4.28%
- 9.Vertex Pharmaceuticals Inc4.27%
- 10.Amgen Inc4.18%